Kirsten rat sarcoma viral oncogene homolog (KRAS) is one of the most common oncogenic drivers in NSCLC, seen in over 30% of lung adenocarcinomas (LUAD), depending on ethnicity and tumor stage and associated with smoking and female patients [3,4,5]. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.